Blackthorn

Other Names

AbrunheiroÀirneBlackthorn plumČierny trnCiruelo silvestreDraenen DduDraigheanDruparia spinosa Clairv.Dygioji slyvaElorri beltzaEndrinoÉpine noireĒrkšķu plūmeEspino negroGewöhnliche SchleheHei ci liKökényLaukapuuMother of the woodOratuomiPorumbarPrugnoloPrunellierPrunus acacia CrantzPrunus acacia-germanica CrantzPrunus communis subinermis ClavaudPrunus communis var. spinosa (L.) Hook. & Arn.Prunus curdica Fenzl ex FritschPrunus densa Martrin-DonosPrunus densiflora Jord. & Fourr.Prunus domestica var. spinosa (L.) KuntzePrunus ericiflora A.Sav.Prunus glomerata A.Sav.Prunus insititia var. spinosa (L.) WestonPrunus kurdica Fenzl ex FritschPrunus polymorpha spinosa (L.) Griess.Prunus spinosaPrunus spinosa L.Prunus spinosa subsp. euspinosa DominRhamnus saxatilis f. inermis LangeRhamnus saxatilis var. inermis (Lange) Willk.SchlehdornSchleheSchwarzdornSlåenSlånSlåpetornSleedoornSloeSloe bushSloe plumSloeberrySpino neroTrninaTёрнWild plumWishing thornТрънка

Synopsis

Blackthorn (Prunus spinosa L.): A Comprehensive Reference

1. Identity and Botanical Profile

Taxonomic Classification and Nomenclature

Blackthorn (Prunus spinosa L.) is a species of flowering plant in the rose family, Rosaceae. This binomial nomenclature was formally established by the Swedish botanist Carl Linnaeus in his seminal work Species Plantarum published in 1753, where Prunus spinosa was described as a distinct species within the Rosaceae family. The genus name Prunus refers to the plum tree, as used in ancient Roman texts to denote trees bearing plum-like fruits; the specific epithet spinosa stems from the Latin adjective spinosus, meaning "thorny" or "full of spines," a direct reference to the plant's prominent sharp thorns.

The plant is commonly known as blackthorn and sloe. The common name "blackthorn" is due to the thorny nature of the shrub and its very dark bark; it has a much darker bark than the whitethorn (hawthorn), to which it is contrasted. The word commonly used for the fruit, "sloe," comes from Old English slāh, cognate with Old High German slēha, slēwa, and Modern German schlehe.

Morphology and Habitat

Blackthorn is a large deciduous shrub or small tree growing to 5 metres tall, with blackish bark and dense, stiff, spiny branches. The leaves are oval, 2–4.5 centimetres long and 1.2–2 cm broad, with a serrated margin. Blackthorn is a hermaphrodite, meaning both male and female reproductive parts are found in one flower; white flowers appear on short stalks before the leaves in March and April, either singularly or in pairs. After pollination by insects, the flowers develop into blue-black fruits measuring 1 cm across.

The plant is native to Europe and West Asia, and has been naturalised in parts of North America. Blackthorn belongs to the rose family and is a deciduous shrub, native to Europe, Western Asia and Northern Africa. It is typically found on the edges of woodlands and meadows or in hedgerows.

Plant Parts Used

All major parts of the plant — the fruits (sloes), flowers, leaves, branches/bark, and root bark — have been used medicinally or culinarily. The blackthorn fruit is a small, spherical, bluish-black drupe with a purple-blue frostlike bloom and yellow-greenish pulp. When fresh, the sloe plums have an astringent flavour; thus, they are harvested after being mellowed by frost and preferably consumed after processing into jams, jellies, juices, and alcoholic beverages, including wines, liqueurs, and tinctures.

Common Preparations and Dosage Forms

Blackthorn enters commerce and traditional practice in numerous forms. Blackthorn is a source of edible fruits — fresh plums are used to make syrups, juice, wine, liqueurs, and tinctures, while dried sloes are added to herbal teas. The fruit is used to make sloe gin in Great Britain and patxaran in Basque Country. The flowers, bark, leaves and fruits are used as aperient, astringent, depurative, diaphoretic, diuretic, febrifuge, laxative and stomachic preparations. An infusion of the flowers is used in the treatment of diarrhoea (especially for children), bladder and kidney disorders, and stomach weakness. Topical preparations including mouthwashes and gargles from fruit juice or leaf infusions have also been recorded. Dried plant material is available as tea/herbal infusions and in encapsulated supplement form.

2. Traditional and Historical Use

Antiquity and Early European Tradition

In European tradition, Prunus spinosa has been known for over 7,000 years, at first as a source of edible fruit and then also as a medicinal plant. It is a traditional medicinal plant of Central and Eastern Europe, historically indicated for the treatment of urinary tract disorders, inflammation, and adjunctive therapy of cardiovascular diseases.

Medicinal Applications Across European Cultures

In many countries, blackthorn fruit is a traditional herbal remedy recommended to treat inflammation-related disorders within the gastrointestinal and urinary tracts, respiratory system, and topically in oral and pharyngeal mucosa inflammation. Moreover, the fruit is used to treat diarrhoea, metabolic diseases (including diabetes and obesity) and as a heart-strengthening and anti-hypertensive agent.

Branches have been more popular in the south of Europe and have been suggested to possess anti-hypertensive properties. In some countries, branch infusions are used in the treatment of hypertension, and the macerated fruits are used for gastrointestinal disturbances.

Historically, the flowers, fruits, and leaves of the plant have been used in folk medicine to treat digestive disorders, urinary complaints, inflammation, and cardiovascular issues. The small tree or shrub also has a firm place in folk history and medicine in the British Isles.

Sebastian Kneipp and German Naturopathic Tradition

Sebastian Kneipp, a renowned German priest and inventor of the Kneipp method, called blackthorn flowers "the mildest laxative that should not be missing in any home pharmacy." The German Commission E, the official body evaluating herbal medicines in Germany, recognised this use. The German Commission E Monographs, a therapeutic guide to herbal medicine, approve Prunus spinosa (sloe/blackthorn) for inflammation of the mouth and pharynx.

Gemmotherapy Tradition

In the European tradition of gemmotherapy — a practice using embryonic plant tissues (buds and shoots) as therapeutic agents — blackthorn buds hold a specific place. The buds of Prunus spinosa have been claimed in this tradition to reactivate the hypothalamus-pituitary-adrenal axis and stimulate the immune system, with biochemical action said to allow the reactivation of purine turnover and stimulation of the endocrine part of the pancreas. It must be noted that these claims originate from gemmotherapy literature rather than randomised controlled trials.

Culinary and Non-Medicinal Traditional Uses

Despite the lack of sweetness, sloes are used for many different purposes, such as to produce jelly, syrup and liqueurs. The bark can be used as a red dye, historically used for colouring, and the dried leaves act as a tobacco substitute. Blackthorn wood has been used for centuries for tent pegs, walking sticks, the traditional Irish shillelagh or cudgel, and for piercing holes in leather.

3. Key Phytochemical Constituents

Overview of Polyphenol Richness

Blackthorn is chemically distinguished by its exceptional richness in polyphenolic compounds across all its major plant parts. Phytochemical investigations reveal that Prunus species are rich in phenolic acids, flavonoids, anthocyanins, tannins, terpenoids, and cyanogenic glycosides, which contribute to a broad spectrum of biological activities. Blackthorn fruits are an abundant source of various compounds, including phenolic compounds such as flavonoids, coumarins, phenolic acids, and A-type proanthocyanidins, as well as pectin, vitamins, minerals, and organic acids.

Phenolic Acids

Fractionation of P. spinosa fruit extracts enables the enrichment of polyphenols up to 126.5 mg gallic acid equivalents/g dry weight total contents, with 91.3 mg/g phenolic acids (including caffeoyl-, coumaroyl-, and feruloylquinic acids). HPLC analysis of blackthorn fruits shows high chlorogenic and neochlorogenic acid levels, followed by glycosides of quercetin.

Flavonoids

Flavonoids make up approximately 41.1 mg/g in enriched fruit fractions, composed mostly of quercetin mono-, di- and triglycosides. Some blackthorn constituents, such as flavonoid pentosides (arabinosides, xylosides, rhamnosides) and A-type procyanidin dimers with twice-bonded structures, are quite rare in nature and their distribution is generally limited to selected species and plant families.

Proanthocyanidins (Condensed Tannins)

Condensed proanthocyanidins amount to 44.5 mg/g in enriched fruit fractions. Active components of the plant include A-type proanthocyanidins, forming unique and diversified profiles in particular organs, among which the flowers are the least characterised. Fingerprinting of flower extracts led to full or partial identification of 57 marker constituents — 36 new for the flowers — mostly flavonoids, A-type proanthocyanidins, and phenolic acids.

Anthocyanins

The four main anthocyanins identified by comparison with literature data and pure standards are cyanidin-3-O-glucoside, cyanidin-3-O-rutinoside, peonidin-3-O-glucoside, and peonidin-3-O-rutinoside. Anthocyanins (cyanidin and peonidin glycosides) are present at approximately 9.2 mg/g in enriched fruit fractions.

Flower-Specific Constituents

Flower extracts contain up to 584.07 mg/g dry weight total phenolics, 490.63 mg/g flavonoids, 109.43 mg/g proanthocyanidins, and 66.77 mg/g phenolic acids, making the flowers among the richest polyphenol sources in the plant.

Cyanogenic Glycosides

Prunus species accumulate secondary metabolites including the cyanogenic glucosides prunasin and amygdalin throughout all parts of the tree. Prunasin (a cyanogenic monoglucoside) is present mainly in the vegetative parts (leaves, stems and roots) and in the early stages of ripening seeds. Like many other stone fruits, the seed in the stone contains trace amounts of hydrogen cyanide. This safety-relevant constituent is discussed further below.

4. Established and Proposed Mechanisms of Action

Free Radical Scavenging and Antioxidant Activity

Activity of ethanol, ethyl acetate and aqueous extracts of blackthorn branches demonstrated higher scavenging capacity compared to other analysed extracts in DPPH assays. In chemical in vitro tests of antioxidant (DPPH, FRAP, TBARS) and enzyme inhibitory activity, the extracts' effects were profound, dose-, phenolic-, and extraction solvent-dependent. Moreover, at in vivo-relevant levels (1–5 μg/mL), the extracts effectively protected human plasma components against peroxynitrite-induced damage (reducing levels of 3-nitrotyrosine, lipid hydroperoxides, and thiobarbituric acid-reactive substances) and enhanced the total antioxidant status of plasma.

Anti-inflammatory Enzyme Inhibition

Both lipoxygenase and hyaluronidase, which are targets of many synthetic drugs used in anti-inflammatory therapies, can be significantly inhibited by plant extracts containing phenolics. The investigated P. spinosa flower extracts, rich in polyphenols, were found to be inhibitors of both enzymes; the activity of the most active fractions was between those of the commercial agents indomethacin (an NSAID) and rutin (a flavonoid vasoprotective agent).

Modulation of Immune Cell Signalling

The hydroalcoholic extract and phenolic-enriched fractions of blackthorn fruits revealed significant ability to modulate pro-oxidant, pro-inflammatory, and anti-inflammatory functions of human neutrophils and peripheral blood mononuclear cells (PBMCs): they strongly downregulated the release of reactive oxygen species, TNF-α, and neutrophil elastase, upregulated the secretion of IL-10, and slightly inhibited the production of IL-8 and IL-6 in cells stimulated by fMLP, fMLP+cytochalasin B, and LPS, depending on the test.

Anticoagulant / Antithrombotic Mechanisms

Flavonol and A-type procyanidin-rich flower extracts directly inhibit thrombin, a critical serine protease in hemostasis and a prime anticoagulant drug target, and do not exhibit antiplatelet effects. Circular dichroism spectroscopy confirmed that interactions between thrombin and the compounds (even at 1 μg/mL) induce alterations within the α-helices' secondary structure, resulting in noticeable changes in the enzyme's CD spectrum.

Protection of Plasma Proteins

The mechanism of action of blackthorn extracts in the protection of plasma proteins and lipids probably involves direct scavenging of peroxynitrite or secondary radicals formed in induced chain reactions. All analysed metabolites effectively protected fibrinogen against the nitration of tyrosine residues with inhibition at the level of 23.9–31.7% and 95.5–97.1% at 1 μg/mL and 50 μg/mL, respectively. At 5 μg/mL, inhibitory percentage was over 85%.

Wound Healing and Anti-Ageing Pathways

In cellular models, blackthorn fruit extract treatment increased miR-146a and decreased IRAK-1 and IL-6 expression levels in LPS-treated human vascular endothelial cells. Plant polyphenols may affect inflammation and associated disorders not only as antioxidants but also as modulators of inflammatory redox signalling pathways, with a positive effect on wound healing.

5. Scientific Evidence by Area of Use

5.1 Antioxidant Activity

The antioxidant properties of P. spinosa extracts represent the most extensively studied area of activity, with evidence from laboratory chemistry, cell models, and limited ex vivo human immune cell work.

Research demonstrates that blackthorn fruits are a rich source of phenolic compounds with antioxidant activity, which are best extracted with methanol or methanol-water. In extraction studies, antioxidant activity decreased in the order: methanol > methanol-water > water (IC₅₀ = 1.33 mg/mL for DPPH), correlated with total polyphenol content (369 mg/100g > 244 mg/100g > 101 mg/100g) and total anthocyanin content (37.11 mg/100g > 16.33 mg/100g > 7.76 mg/100g).

Evidence strength: This evidence is primarily preclinical (in vitro/ex vivo). No randomised controlled trials in humans have evaluated blackthorn specifically for measurable antioxidant endpoints. The ex vivo human immune cell models are mechanistically informative but do not substitute for clinical trials.

5.2 Anti-inflammatory Activity

The results support the traditional use of fresh blackthorn fruits in inflammatory disorders and indicate extracts that are most promising for functional applications. The key 2022 study used two ex vivo models of human immune cells (neutrophils and PBMCs), making it one of the stronger pre-clinical models available, but it is not a clinical trial.

Evidence strength: Preliminary. The mechanistic data from human cell models are supportive but there are no published randomised controlled trials (RCTs) in human subjects specifically evaluating anti-inflammatory outcomes for blackthorn preparations.

5.3 Cardiovascular and Haemostatic Effects

Research confirms that antioxidant activity of P. spinosa flower extracts may be crucial in understanding their beneficial effects in cardiovascular disease in vivo. The analysed extracts not only enhanced the total antioxidant status of peroxynitrite-treated plasma but also effectively reduced the levels of well-known oxidative stress biomarkers — products of protein nitration (3-nitrotyrosine) and lipid peroxidation (hydroperoxides and TBARS).

A dedicated 2023 study on anticoagulant properties found that the study investigated the effects of flavonol and A-type procyanidin-rich blackthorn flower extracts on the hemostatic system, including the blood plasma coagulation cascade and platelet aggregation. Six distinct extracts were assessed at in vivo-relevant levels (1–50 μg/mL) for their antithrombotic activity. The findings indicate that the extracts do not significantly impact platelet haemostasis. These findings contribute to the understanding of the potential medical applications of P. spinosa flowers in preventing and treating cardiovascular diseases. However, additional research is needed to understand their impact on the haemostatic system, including interactions with other coagulation cascade factors and fibrinolytic proteins.

Evidence strength: Preclinical only (in vitro and plasma-based models). The in vitro anticoagulant data are mechanistically interesting but no human clinical cardiovascular trial data for blackthorn extracts per se have been published.

5.4 Antimicrobial Activity

Ethanol extract of P. spinosa fruit showed both antimicrobial and antifungal activity. Antibacterial activity of a P. spinosa fruit ethanol extract against S. aureus has been described, with an MBC value of approximately 16–17.44 mg/mL.

Evidence strength: Preliminary in vitro data only. No clinical trials have been conducted to evaluate blackthorn preparations for treating human infections.

5.5 Antidiabetic and Metabolic Effects

The polyphenol-rich blackthorn fruits, both fresh and dried, are pleiotropic ethnomedicines indicated to treat gastrointestinal and urinary inflammations, diarrhoea, and metabolic diseases, including diabetes and obesity. Although ethnopharmacological sources suggest the potential of blackthorn fruits in the prophylaxis and therapy of diabetes mellitus and its cardiovascular pathologies, the relevant activity mechanisms and vectors are still insufficiently recognised. Most of the earlier works focused on anti-inflammatory properties: the extracts were proved to downregulate the pro-inflammatory response of human immune cells and inhibit the expression of adhesion molecules in human endothelial cells.

The potential direct antidiabetic properties of sloe fruits have been analysed to date only by Popović et al. indicating this is a very sparse evidence base.

Evidence strength: Very preliminary. Evidence is predominantly from in vitro enzyme inhibition assays (α-glucosidase and α-amylase inhibition) and cell models. No human clinical trials on glycaemic outcomes have been published.

5.6 Cytotoxic and Potential Anticancer Activity

A Prunus spinosa Trigno ecotype drupe extract combined with a nutraceutical activator complex (NAC) has shown in vitro anticancer activity. The cytotoxic effect was evaluated on human cancer cells with an initial screening on colorectal, uterine cervical, and bronchoalveolar cells. The viability reduction of HCT116 and SW480 colon carcinoma cells after treatment with (PsT 10 mg/mL + NAC) was about 40% (p < 0.05), compared to control cells.

Branch extracts demonstrated potent radical scavenging activity (IC₅₀ 1.02 ± 0.25 mg/mL), dose-dependent cytotoxicity, and higher sensitivity of HeLa tumour cells. Genotoxic effects were significantly more pronounced in tumour cells than in normal ones, highlighting condensed tannins' selective antitumour properties.

Methanol extracts of P. spinosa fruit have been reported to have cytotoxic effects on brain cancer cell lines.

Evidence strength: Early-stage in vitro / preclinical only. These results are exploratory and do not constitute clinical evidence of anticancer efficacy in humans.

5.7 Wound Healing

A Prunus spinosa fruit ethanol extract, with a peculiar content of biologically active polyphenols, was investigated for its wound healing capacity. Anti-inflammatory properties were tested on young and senescent LPS-treated human umbilical vein endothelial cells (HUVECs). The PSF antioxidant effect was validated in vitro with DPPH assay and confirmed by in vivo treatments in C. elegans. The findings showed beneficial effects on the worms' lifespan and healthspan with positive outcomes on longevity markers.

Evidence strength: Preliminary preclinical. Cell line and invertebrate model evidence only; no clinical wound healing trials in humans.

5.8 Oral and Pharyngeal Mucosa Inflammation (Regulatory Recognition)

The German Commission E Monographs approve Prunus spinosa for inflammation of the mouth and pharynx, making this the most formally recognised indication with regulatory-level backing in Europe, albeit on the basis of traditional use rather than modern RCT evidence. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines has approved the use of this herb for getting rid of mild inflammation of mouth and pharyngeal mucosa.

6. Body Systems and Health Areas Associated With Blackthorn

Cardiovascular system: Blackthorn has been widely studied for its potential in managing cardiovascular diseases, with its fruits traditionally consumed in various forms such as juices, wines and tinctures.
Gastrointestinal system: Blackthorn fruits are traditional ethnomedicines indicated to treat gastrointestinal and urinary inflammations and diarrhoea.
Urinary tract: Blackthorn is a traditional medicinal plant of Central and Eastern Europe indicated for the treatment of urinary tract disorders.
Immune system: Extracts have been shown to modulate the pro-oxidant, pro-inflammatory, and anti-inflammatory functions of human neutrophils and peripheral blood mononuclear cells.
Haemostatic / coagulation system: Flower extracts directly inhibit thrombin, a critical serine protease in haemostasis.
Oral and upper respiratory mucosa: Traditional and Commission E–recognised use for mild inflammation of the mouth and pharynx.
Skin and wound healing: Many studies have found beneficial effects on the wound healing process and cytotoxic activity on some cancer cell lines.
Metabolic / endocrine (diabetes/obesity): Blackthorn has been studied for its potential in managing diabetes, though clinical evidence remains absent.

7. Dosage Forms and Reported Dosages

There are no standardised, EMA/ESCOP-approved dosages specific to blackthorn for systemic conditions; the doses below reflect what has appeared in traditional literature and pharmacological studies.

Flower Infusion / Tea

An infusion of the flowers is used in the treatment of diarrhoea (especially for children), bladder and kidney disorders, and stomach weakness. Flower preparations in European herbal traditions are typically taken as simple aqueous infusions.

Fruit Preparations

A blackthorn gargle is made by brewing an infusion of two to four grams of dried fruit; fresh fruit juice can also be gargled and is used to reduce mouth and throat inflammation. Scientific studies have worked with standardised extracts at concentrations of 1–100 μg/mL for cell-based assays and at 1–50 μg/mL for coagulation studies; these concentrations are research parameters and do not translate directly to oral dosing.

Leaf and Bark Preparations

The bark, leaves and fruits are used as astringent and stomachic preparations. Leaf infusions have been applied topically for oral inflammation. No validated daily dose for leaf or bark preparations has been established through clinical trials.

Commercial Supplement Forms

Dried leaves and berries of blackthorn are finely ground and consumed in encapsulated supplemental forms, which offer standardised doses while sparing the herb's bitter flavour. No standardised potency specifications for such commercial preparations are backed by clinical trial dosing data at this time.

8. Safety Considerations and Interactions

Cyanogenic Glycoside Content (Seeds)

The most important safety concern with blackthorn is the presence of cyanogenic glycosides in the seeds and other plant parts. Prunus species accumulate cyanogenic glucosides prunasin and amygdalin throughout all parts of the tree. Prunasin is present mainly in the vegetative parts (leaves, stems and roots) and in early stages of ripening seeds. Many Prunus species contain cyanogenic glucosides such as amygdalin, which yields the toxic compound hydrogen cyanide (HCN) on hydrolysis, and they may be toxic if ingested in raw state or larger quantities. Hydrolysis of the cyanogenic glycosides occurs in the gastrointestinal tract. Consumption of intact ripe fruit flesh and juice in normal food/beverage amounts poses minimal cyanide risk; the hazard is primarily associated with crushing or chewing the seeds.

Cellular Safety Data for Extracts

Where tested in research settings, polyphenol-rich extracts have demonstrated acceptable safety in human cell models. In cytotoxicity tests, blackthorn flower extracts did not affect the viability of human peripheral blood mononuclear cells (PBMCs), and might be regarded as safe at the concentrations tested. Cellular safety was confirmed for the fruit extracts by flow cytometry in a wide range of concentrations.

Anticoagulant Drug Interactions (Theoretical)

The in vitro demonstration of direct thrombin inhibition by blackthorn flower extracts contributes to understanding potential medical applications in cardiovascular disease, but additional research is needed to understand interactions with other coagulation cascade factors and fibrinolytic proteins. These findings indicate a theoretical interaction risk with anticoagulant or antiplatelet medications; however, no clinical pharmacokinetic or interaction data in humans have been published. The pharmacological significance in vivo remains unclear.

Astringency and Gastrointestinal Tolerance

The dark blue fruits of the blackthorn (sloes) are edible but have a very bitter and astringent flavour. The high tannin content responsible for this astringency can cause gastrointestinal discomfort at excessive intakes, consistent with the general pharmacology of tannin-rich preparations.

In Vitro Digestion Stability

Buccal and gastric digestion had no substantial effect on any of the phenolic compounds in blackthorn extracts. However, these compounds were significantly altered during intestinal digestion. This suggests that bioavailability and activity of native polyphenols may differ considerably from the values measured in cell-free in vitro assays.

Absence of Published Formal Safety Monograph

At the time of writing, Prunus spinosa flowers and fruits do not appear to have a finalised full European Union herbal monograph from the EMA/HMPC covering systemic indications — only the German Commission E recognition for topical use in oral mucosal inflammation has been established at the regulatory level. Formal contraindication, interaction, and adverse event data sets of the kind found in EMA monographs are therefore not available for this plant.

9. Summary of Evidence Quality

The body of research on Prunus spinosa is substantial in terms of phytochemical characterisation and in vitro/ex vivo bioactivity but remains at an early stage with respect to human clinical evidence. The plant has been identified as a traditional medicinal herb across multiple European cultures for millennia, and its polyphenol-rich profile provides a plausible mechanistic basis for several of its traditional applications. However, as of the most recent literature reviewed:

The previous research on the biological activity of P. spinosa fruits has focused mainly on antioxidant potential, with some data available on antidiabetic, antimicrobial, anti-inflammatory and anticancer activity. All of these remain at the preclinical or preliminary level.
The first report on the antioxidant and anti-inflammatory activity of fresh fruits of P. spinosa in normal human immune cells ex vivo was published in 2022, illustrating how recently even basic human-relevant bioactivity work has begun.
No registered RCTs evaluating blackthorn preparations for any health indication in humans have been identified in the peer-reviewed literature.
Reviews underscore the value of integrating traditional ethnobotanical and ethnopharmacological knowledge with contemporary scientific research to explore novel applications of these underutilised wild fruits.

References

Health Conditions

Health conditions that Blackthorn may help support.

No conditions available.

Body Systems

Body systems that Blackthorn may help support.

No body systems available.